OncoBriefs - Oncology Research News

Some molecular tweaks are basically a cellular outfit change - and in glioblastoma, ERO1alpha seems to be the stylist from hell, helping cancer cells swap sensible daywear for full black-turtleneck mastermind mode.

In healthy tissue, the neighborhood usually has zoning laws - cells mind their business, utilities run on time, and nobody builds a nightclub in a cul-de-sac. Tumors, meanwhile, are the part of town where the streetlights flicker, the permits are fake, and some very suspicious chemistry keeps...

That’s right—according to new research, your gut bacteria might be running a secret underground railroad for cancer stem cells, complete with metabolic tunnels and chemical disguises. And you thought your microbiome’s worst crime was giving you gas after tacos.

For years, prostate cancer screening has operated like a hiring manager with a suspiciously narrow LinkedIn filter - plenty of confidence, not enough fairness. Now the UK is adjusting the guest list. A new trial highlighted in The Lancet Oncology will include more Black men, a change that sounds...

At 3 AM in a lab in Munich, someone was probably staring at pancreatic tumor data and having the sort of thought that either wins prizes or ruins sleep: what if a vitamin D-related drug could make chemotherapy work better in one of the stingiest cancers on earth?

A garden looks simple until you knead the soil and realize half the weeds are freeloaders, some are invasive masterminds, and a few are somehow thriving on fertilizer meant for everything else. Acute myeloid leukemia - AML, one of the nastier blood cancers in the shed - has that exact energy. It...

Severance gave us a nice recent lesson in how much chaos can happen when communication gets weird inside a system. Cancer, naturally, looked at that premise and said, cute, but what if we also added molecular sabotage. That is more or less where circular RNAs - circRNAs, because oncology loves a...

Pancreatic cancer is one of those diseases that makes oncologists age in dog years. Metastatic pancreatic ductal adenocarcinoma has a rough track record, and once standard treatments stop working, the options get thin fast. Not "annoyingly limited." More like "airplane pretzels for dinner" limited.

Colorectal cancer screening sounds like the sort of topic that arrives wearing beige and carrying a clipboard. But this new analysis from the COLONPREV Trial turns out to ask a pretty juicy question: if people actually stick with the plan, is a one-time colonoscopy better than doing a FIT stool...

That is what makes this new paper in Cell Host & Microbe worth your time. Not because it promises a miracle. We have enough miracle headlines already. But because it asks a practical question with real teeth: if measles comes roaring back into a community - and yes, it still can - do we have human...

The Dyatlov Pass mystery has nothing on a mismatch repair-deficient colon tumor - both involve a scene full of clues, missing explanations, and the uncomfortable feeling that something weird happened in the dark. In this case, the mystery is why some colorectal cancers look highly visible to the...

Most cancer drugs arrive like a SWAT team with a blurry address. They mean well, but healthy cells can get caught in the commotion. That has been one of the oldest headaches in metastatic cancer - especially ovarian cancer, where the disease often spreads widely and likes to come back like a...

Some cancer genes do not just switch on like a light. They gather a crowd.

Cancer drug delivery often feels like a city bus system designed by chaos - the treatment arrives late, misses half the stops, and somehow still charges full fare. This new breast cancer study tried a different route: pair standard pre-surgery chemotherapy with anlotinib, a targeted drug that...

In poker, the ugliest hand at the table is the one that looks harmless until somebody flips over a straight. That is more or less the problem with prostate cancer screening - sometimes an MRI shrugs, the risk factors keep waving their arms like a panicked guy at a blackjack table, and doctors still...

Cancer is not just a pile of rogue cells - it is a game where your immune system has already been throwing elbows long before the oncologist walks onto the field. This new Immunity paper suggests that in some untreated human tumors, the immune system has already knocked a bunch of the most visible...

The sample tubes are lined up, the sequencing machines are humming, and years after a colorectal adenoma got snipped out, the gut is still out here leaving fingerprints. That is the basic plot of a new Cell Host & Microbe paper - and honestly, it is a little rude of the microbiome to keep receipts...

39 trillion is roughly the number of microbial cells hanging out in and on a human body, which means you are less a lone individual and more a very opinionated apartment building with legs.

If you’ve never found yourself rooting for a cytochrome P450 enzyme before, buckle up: the molecular saga behind anticancer compounds like cephalotaxinone and homoerythratine is juicier than a soap opera set in a petri dish. So why all the hype about these mouthful-of-consonant alkaloids? For...

Take the left path and you see a tidy tumor cell, sitting there like a suspiciously calm lizard on a sun-warmed rock. Take the right path and the camera pulls back: immune cells crouch in the grass, connective tissue forms thorny underbrush, blood vessels snake through the terrain, and suddenly the...